On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli

被引：7
|
作者：
Tan, HD
Dan, GP
Gong, HY
Cao, LJ
机构：
[1] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian 116023, Peoples R China
[2] Yushui Biopharmaceut Co Ltd, Chongqing 200400, Peoples R China
来源：
BIOTECHNOLOGY LETTERS | 2005年 / 27卷 / 16期
关键词：
human interleukin-1 receptor antagonist; inclusion body; on-column refolding;
D O I：
10.1007/s10529-005-8655-5
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) was produced in E. coli as an inclusion body. rHuIL-1ra was purified to Over 98% purity by anion exchange chromatography after on-column refolding. The optimized processes produced more than 2 g pure refolded rHuIL-1ra per 1 l culture, corresponding to a 44% recovery, without an intermediate dialysis step. Refolded rHuIL-1ra had full biological activity with the MTT assay. An intramolecular disulfide linkage in the oxidized recombinant protein was suggested by data from HPLC and non-reducing SDS-PAGE.
引用
收藏
页码：1177 / 1182
页数：6
相关论文
共 50 条
  • [11] On-column refolding and characterization of soluble human interleukin-15 receptor α-chain produced in Escherichia coli
    Matsumoto, M
    Misawa, S
    Tsumoto, K
    Kumagai, I
    Hayashi, H
    Kobayashi, Y
    PROTEIN EXPRESSION AND PURIFICATION, 2003, 31 (01) : 64 - 71
  • [12] High yield refolding and purification process for recombinant human interleukin-6 expressed in Escherichia coli
    Ejima, D
    Watanabe, M
    Sato, Y
    Date, M
    Yamada, N
    Takahara, Y
    BIOTECHNOLOGY AND BIOENGINEERING, 1999, 62 (03) : 301 - 310
  • [13] High yield refolding and purification process for recombinant human interleukin-6 expressed in Escherichia coli
    Central Research Laboratories, Ajinomoto Co., Inc., 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki 210-8681, Japan
    Biotechnol. Bioeng., 3 (301-310):
  • [14] Refolding and purification of recombinant OsNifU1A domain II that was expressed by Escherichia coli
    Katoh, S
    Murata, K
    Kubota, Y
    Kumeta, H
    Ogura, K
    Inagaki, F
    Asayama, M
    Katoh, E
    PROTEIN EXPRESSION AND PURIFICATION, 2005, 43 (02) : 149 - 156
  • [15] PURIFICATION AND CHARACTERIZATION OF HUMAN INTERLEUKIN-1-BETA EXPRESSED IN RECOMBINANT ESCHERICHIA-COLI
    WINGFIELD, P
    PAYTON, M
    TAVERNIER, J
    BARNES, M
    SHAW, A
    ROSE, K
    SIMONA, MG
    DEMCZUK, S
    WILLIAMSON, K
    DAYER, JM
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 160 (03): : 491 - 497
  • [16] INVIVO ANTIINFLAMMATORY PROPERTIES OF RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA)
    COMINELLI, F
    LLERENA, R
    CLARK, BD
    NAST, CC
    THOMPSON, RC
    DINARELLO, CA
    LYMPHOKINE RESEARCH, 1990, 9 (04): : 597 - 597
  • [17] COMPARATIVE RESPONSES OF HUMAN AND RABBIT INTERLEUKIN-1 INVIVO - EFFECT OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST
    VONUEXKULL, C
    NOURSHARGH, S
    WILLIAMS, TJ
    IMMUNOLOGY, 1992, 77 (04) : 483 - 487
  • [18] Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration
    Meyer, Nuala J.
    Reilly, John P.
    Anderson, Brian J.
    Palakshappa, Jessica A.
    Jones, Tiffanie K.
    Dunn, Thomas G.
    Shashaty, Michael G. S.
    Feng, Rui
    Christie, Jason D.
    Opal, Steven M.
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 21 - 28
  • [19] Refolding and reconstitution of human recombinant Bax inhibitor-1 into liposomes from inclusion bodies expressed in Escherichia coli
    Ahn, Taeho
    Yun, Chul-Ho
    Chae, Ho Zoon
    Kim, Hyung-Ryong
    Chae, Han-Jung
    PROTEIN EXPRESSION AND PURIFICATION, 2009, 66 (01) : 35 - 38
  • [20] Refolding and purification of recombinant human interferon-γ expressed as inclusion bodies in Escherichia coli using size exclusion chromatography
    Guan, YX
    Pan, HX
    Gao, YG
    Yao, SJ
    Cho, MG
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2005, 10 (02) : 122 - 127
12345